Attached files

file filename
EX-32.2 - EX-32.2 - Viela Bio, Inc.vie-ex322_7.htm
EX-31.2 - EX-31.2 - Viela Bio, Inc.vie-ex312_8.htm
EX-31.1 - EX-31.1 - Viela Bio, Inc.vie-ex311_9.htm
EX-23.1 - EX-23.1 - Viela Bio, Inc.vie-ex231_520.htm
EX-21.1 - EX-21.1 - Viela Bio, Inc.vie-ex211_188.htm
EX-10.24 - EX-10.24 - Viela Bio, Inc.vie-ex1024_597.htm
EX-10.22 - EX-10.22 - Viela Bio, Inc.vie-ex1022_187.htm
EX-4.3 - EX-4.3 - Viela Bio, Inc.vie-ex43_344.htm
10-K - 10-K - Viela Bio, Inc.vie-10k_20191231.htm


Exhibit 32.1


Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Viela Bio, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge that:

The Annual Report for the year ended December 31, 2019 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: March 25, 2020



/s/ Zhengbin (Bing) Yao, Ph.D.




Zhengbin (Bing) Yao, Ph.D.




Chief Executive Officer

(Principal Executive Officer)